---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004298"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:18:05.934299+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Processa closes $5M public offering; Series A/B warrants at $0.65 exercise price

## Summary
- Gross proceeds of $5.0M from offering closed Jan 29, 2025; net proceeds for general corporate purposes.
- Offered 8,050,672 shares (or pre-funded warrants) at combined price of $0.615 (institutions) / $0.7975 (CEO/board) with Series A and B warrants.
- Series A warrants exercisable at $0.65 for 5 years, Series B at $0.65 for 18 months, both subject to stockholder approval.
- CEO and certain board members participated alongside a healthcare-focused institutional investor; A.G.P. acted as sole placement agent.
- Company to seek stockholder approval within 90 days for warrant share issuance; otherwise will call meetings every 90 days.

## SEC filing metadata
- accession: 0001493152-25-004298
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315225004298/0001493152-25-004298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225004298/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004298
- JSON: https://secwatch.observer/filing/0001493152-25-004298.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.